StockWatch: Insilico Projects Profit, Revenue Leaps as AI-Developed Lead Candidate Moves to Phase III - Genetic Engineering and Biotechnology News

A company using AI to develop new drugs has advanced a candidate into later-stage testing, suggesting AI tools can speed up drug discovery. This matters because faster drug development could bring new treatments to patients sooner.